Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Sunitinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Hesperidin Potential treatment - theoretical effect Natural product Antiviral Oct/27/2020 6 0
Lupinifolin Potential treatment - theoretical effect Natural product Antiviral Oct/21/2020 1 0
VH2 A01-B01 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VH2 A01-B02 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VH3 B01 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
SARS-CoV-2 HRC lipopeptide Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
Excel (.xslx) CSV (.csv)